Global Oncology Drugs Market Size, Share, Growth & Forecast 2025

About This Presentation
Title:

Global Oncology Drugs Market Size, Share, Growth & Forecast 2025

Description:

Global oncology drugs market is projected to grow at a brisk rate over the forecast period owing to widespread prevalence of cancer, globally. Various other related factors which are contributing to the growth of oncology drugs market include rise in geriatric population worldwide, increase in global healthcare expenditure, rising number of product approvals by regulatory bodies and growing R&D activities for the development of new cancer drugs. – PowerPoint PPT presentation

Number of Views:17

less

Transcript and Presenter's Notes

Title: Global Oncology Drugs Market Size, Share, Growth & Forecast 2025


1
2015 2025
GLOBAL ONCOLOGY DRUGS MARKET FORECAST
OPPORTUNITIES
2
  • Scope of Report
  • Product of Interest (POI) Oncology Drugs

Global oncology drugs market is projected to grow
at a brisk rate over the forecast period owing to
widespread prevalence of cancer, globally.
Various other related factors which are
contributing to the growth of oncology drugs
market include rise in geriatric population
worldwide, increase in global healthcare
expenditure, rising number of product approvals
by regulatory bodies and growing RD activities
for the development of new cancer drugs.
Furthermore, emergence of biosimilar products for
cancer treatment, increasing collaborations
between pharmaceutical companies and development
of pipeline oncology products are providing
opportunities for various oncology drug
manufacturers.
Market Segmentation
THERAPY
DISTRIBUTION CHANNEL
CANCER TYPE
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Government Hospitals
  • Lung Cancer
  • Stomach Cancer
  • Colorectal Cancer
  • Breast Cancer
  • Prostate Cancer
  • Liver Cancer
  • Esophagus Cancer
  • Cervical Cancer
  • Kidney Cancer
  • Bladder Cancer
  • Others
  • Chemotherapy
  • Targeted Therapy
  • Immunotherapy (Biologic Therapy)
  • Hormonal Therapy
  • Others

DRUG THERAPY
  • Adjuvant
  • Neoadjuvant
  • Concurrent

ROUTE OF ADMINISTRATION
DRUG TYPE
  • Oral
  • Intravenous
  • Subcutaneous
  • Others
  • Cytotoxic Drugs
  • Targeted Drugs
  • Hormonal Drugs

GENDER
  • Male
  • Female

3
  • Table of Contents

S. No. Contents Contents Contents Page No.
1. Product Overview Product Overview Product Overview
2. Research Methodology Research Methodology Research Methodology
3. Impact of COVID-19 on Global Oncology Drugs Market Impact of COVID-19 on Global Oncology Drugs Market Impact of COVID-19 on Global Oncology Drugs Market
4. Executive Summary Executive Summary Executive Summary
5. Voice of Customer Voice of Customer Voice of Customer
6. Global Oncology Drugs Market Outlook Global Oncology Drugs Market Outlook Global Oncology Drugs Market Outlook
6.1. Market Size Forecast Market Size Forecast
6.1.1. By Value
6.2. Market Share Forecast Market Share Forecast
6.2.1. By Drug Type (Cytotoxic Drugs, Targeted Drugs, Hormonal Drugs)
6.2.2. By Therapy (Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy, Others) By Therapy (Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy, Others)
6.2.3. By Drug Therapy (Adjuvant, Neoadjuvant and Concurrent)
6.2.4. By Route of Administration (Oral, Intravenous, Subcutaneous, Others) By Route of Administration (Oral, Intravenous, Subcutaneous, Others)
6.2.5. By Gender (Male, Female) By Gender (Male, Female)
6.2.6. By Cancer Type (Lung Cancer, Stomach Cancer, Colorectal Cancer, Breast Cancer, Prostate Cancer, Liver Cancer, Esophagus Cancer, Cervical Cancer, Kidney Cancer, Bladder Cancer, Others) By Cancer Type (Lung Cancer, Stomach Cancer, Colorectal Cancer, Breast Cancer, Prostate Cancer, Liver Cancer, Esophagus Cancer, Cervical Cancer, Kidney Cancer, Bladder Cancer, Others)
6.2.7. By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Government Hospitals) By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Government Hospitals)
6.2.8. By Company (2019)
6.2.9. By Region (Asia-Pacific, Europe, North America, South America and Middle East Africa)
6.3. Product Market Map Product Market Map Product Market Map
4
  • Table of Contents

S. No. Contents Contents Contents Contents Contents Page No.
7. Asia-Pacific Oncology Drugs Market Outlook Asia-Pacific Oncology Drugs Market Outlook Asia-Pacific Oncology Drugs Market Outlook Asia-Pacific Oncology Drugs Market Outlook Asia-Pacific Oncology Drugs Market Outlook
7.1. Market Size Forecast Market Size Forecast Market Size Forecast
7.1.1. By Value By Value By Value
7.2. Market Share Forecast Market Share Forecast Market Share Forecast Market Share Forecast
7.2.1. By Drug Type By Drug Type By Drug Type
7.2.2. By Therapy By Therapy By Therapy
7.2.3. By Drug Therapy By Drug Therapy By Drug Therapy
7.2.4. By Route of Administration By Route of Administration By Route of Administration
7.2.5. By Gender By Gender By Gender
7.2.6. By Cancer Type By Cancer Type By Cancer Type
7.2.7. By Country (China, India, Australia, Japan, South Korea) By Country (China, India, Australia, Japan, South Korea) By Country (China, India, Australia, Japan, South Korea)
7.3. Asia-Pacific Country Analysis Asia-Pacific Country Analysis Asia-Pacific Country Analysis Asia-Pacific Country Analysis
7.3.1. China Oncology Drugs Market Outlook China Oncology Drugs Market Outlook China Oncology Drugs Market Outlook
7.3.1.1. Market Size Forecast Market Size Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share Forecast Market Share Forecast
7.3.1.2.1. By Drug Type
7.3.1.2.2. By Therapy
7.3.1.2.3. By Drug Therapy
7.3.1.2.4. By Route of Administration
7.3.1.2.5. By Gender
7.3.1.2.6. By Cancer Type
5
  • Table of Contents

S. No. Contents Contents Contents Contents Contents Page No.
7.3.2. India Oncology Drugs Market Outlook India Oncology Drugs Market Outlook India Oncology Drugs Market Outlook
7.3.2.1. Market Size Forecast Market Size Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share Forecast Market Share Forecast
7.3.2.2.1. By Drug Type
7.3.2.2.2. By Therapy
7.3.2.2.3. By Drug Therapy
7.3.2.2.4 By Route of Administration
7.3.2.2.5. By Gender
7.3.2.2.6. By Cancer Type
7.3.3. Australia Oncology Drugs Market Outlook Australia Oncology Drugs Market Outlook Australia Oncology Drugs Market Outlook
7.3.3.1. Market Size Forecast Market Size Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share Forecast Market Share Forecast
7.3.3.2.1. By Drug Type
7.3.3.2.2. By Therapy
7.3.3.2.3. By Drug Therapy
7.3.3.2.4. By Route of Administration
7.3.3.2.5. By Gender
7.3.3.2.6. By Cancer Type
6
  • Table of Contents

S. No. Contents Contents Contents Contents Contents Page No.
7.3.4. Japan Oncology Drugs Market Outlook Japan Oncology Drugs Market Outlook Japan Oncology Drugs Market Outlook
7.3.4.1. Market Size Forecast Market Size Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share Forecast Market Share Forecast
7.3.4.2.1. By Drug Type
7.3.4.2.2. By Therapy
7.3.4.2.3. By Drug Therapy
7.3.4.2.4 By Route of Administration
7.3.4.2.5. By Gender
7.3.4.2.6. By Cancer Type
7.3.5. Australia Oncology Drugs Market Outlook Australia Oncology Drugs Market Outlook Australia Oncology Drugs Market Outlook
7.3.5.1. Market Size Forecast Market Size Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share Forecast Market Share Forecast
7.3.5.2.1. By Drug Type
7.3.5.2.2. By Therapy
7.3.5.2.3. By Drug Therapy
7.3.5.2.4. By Route of Administration
7.3.5.2.5. By Gender
7.3.5.2.6. By Cancer Type
7
  • Table of Contents

S. No. Contents Contents Contents Contents Contents Page No.
8. Europe Oncology Drugs Market Outlook Europe Oncology Drugs Market Outlook Europe Oncology Drugs Market Outlook Europe Oncology Drugs Market Outlook Europe Oncology Drugs Market Outlook
8.1. Market Size Forecast Market Size Forecast Market Size Forecast
8.1.1. By Value By Value By Value
8.2. Market Share Forecast Market Share Forecast Market Share Forecast Market Share Forecast
8.2.1. By Drug Type By Drug Type By Drug Type
8.2.2. By Therapy By Therapy By Therapy
8.2.3. By Drug Therapy By Drug Therapy By Drug Therapy
8.2.4. By Route of Administration By Route of Administration By Route of Administration
8.2.5. By Gender By Gender By Gender
8.2.6. By Cancer Type By Cancer Type By Cancer Type
8.2.7. By Country (France, Germany, United Kingdom, Italy, Spain) By Country (France, Germany, United Kingdom, Italy, Spain) By Country (France, Germany, United Kingdom, Italy, Spain)
8.3. Asia-Pacific Country Analysis Asia-Pacific Country Analysis Asia-Pacific Country Analysis Asia-Pacific Country Analysis
8.3.1. France Oncology Drugs Market Outlook France Oncology Drugs Market Outlook France Oncology Drugs Market Outlook
8.3.1.1. Market Size Forecast Market Size Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share Forecast Market Share Forecast
8.3.1.2.1. By Drug Type
8.3.1.2.2. By Therapy
8.3.1.2.3. By Drug Therapy
8.3.1.2.4. By Route of Administration
8.3.1.2.5. By Gender
8.3.1.2.6. By Cancer Type
8
  • Table of Contents

S. No. Contents Contents Contents Contents Contents Page No.
8.3.2. Germany Oncology Drugs Market Outlook Germany Oncology Drugs Market Outlook Germany Oncology Drugs Market Outlook
8.3.2.1. Market Size Forecast Market Size Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share Forecast Market Share Forecast
8.3.2.2.1. By Drug Type
8.3.2.2.2. By Therapy
8.3.2.2.3. By Drug Therapy
8.3.2.2.4 By Route of Administration
8.3.2.2.5. By Gender
8.3.2.2.6. By Cancer Type
8.3.3. United Kingdom Oncology Drugs Market Outlook United Kingdom Oncology Drugs Market Outlook United Kingdom Oncology Drugs Market Outlook
8.3.3.1. Market Size Forecast Market Size Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share Forecast Market Share Forecast
8.3.3.2.1. By Drug Type
8.3.3.2.2. By Therapy
8.3.3.2.3. By Drug Therapy
8.3.3.2.4. By Route of Administration
8.3.3.2.5. By Gender
8.3.3.2.6. By Cancer Type
9
  • Table of Contents

S. No. Contents Contents Contents Contents Contents Page No.
8.3.4. Italy Oncology Drugs Market Outlook Italy Oncology Drugs Market Outlook Italy Oncology Drugs Market Outlook
8.3.4.1. Market Size Forecast Market Size Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share Forecast Market Share Forecast
8.3.4.2.1. By Drug Type
8.3.4.2.2. By Therapy
8.3.4.2.3. By Drug Therapy
8.3.4.2.4 By Route of Administration
8.3.4.2.5. By Gender
8.3.4.2.6. By Cancer Type
8.3.5. Spain Oncology Drugs Market Outlook Spain Oncology Drugs Market Outlook Spain Oncology Drugs Market Outlook
8.3.5.1. Market Size Forecast Market Size Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share Forecast Market Share Forecast
8.3.5.2.1. By Drug Type
8.3.5.2.2. By Therapy
8.3.5.2.3. By Drug Therapy
8.3.5.2.4. By Route of Administration
8.3.5.2.5. By Gender
8.3.5.2.6. By Cancer Type
10
  • Table of Contents

S. No. Contents Contents Contents Contents Contents Page No.
9. North America Oncology Drugs Market Outlook North America Oncology Drugs Market Outlook North America Oncology Drugs Market Outlook North America Oncology Drugs Market Outlook North America Oncology Drugs Market Outlook
9.1. Market Size Forecast Market Size Forecast
9.1.1. By Value By Value By Value
9.2. Market Share Forecast Market Share Forecast
9.2.1. By Drug Type By Drug Type By Drug Type
9.2.2. By Therapy By Therapy By Therapy
9.2.3. By Drug Therapy By Drug Therapy By Drug Therapy
9.2.4. By Route of Administration By Route of Administration By Route of Administration
9.2.5. By Gender By Gender By Gender
9.2.6. By Cancer Type By Cancer Type By Cancer Type
9.2.7. By Country (United States, Mexico, Canada) By Country (United States, Mexico, Canada) By Country (United States, Mexico, Canada)
9.3. North America Country Analysis North America Country Analysis North America Country Analysis North America Country Analysis
9.3.1. United States Oncology Drugs Market Outlook United States Oncology Drugs Market Outlook United States Oncology Drugs Market Outlook
9.3.1.1. Market Size Forecast Market Size Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share Forecast Market Share Forecast
9.3.1.2.1. By Drug Type
9.3.1.2.2. By Therapy
9.3.1.2.3. By Drug Therapy
9.3.1.2.4. By Route of Administration
11
  • Table of Contents

S. No. Contents Contents Contents Contents Contents Page No.
9.3.1.2.5. By Gender
9.3.1.2.6. By Cancer Type
9.3.2. Mexico Oncology Drugs Market Outlook Mexico Oncology Drugs Market Outlook Mexico Oncology Drugs Market Outlook
9.3.2.1. Market Size Forecast Market Size Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share Forecast Market Share Forecast
9.3.2.2.1. By Drug Type
9.3.2.2.2. By Therapy
9.3.2.2.3. By Drug Therapy
9.3.2.2.4 By Route of Administration
9.3.2.2.5. By Gender
9.3.2.2.6. By Cancer Type
9.3.3. Canada Oncology Drugs Market Outlook Canada Oncology Drugs Market Outlook Canada Oncology Drugs Market Outlook
9.3.3.1. Market Size Forecast Market Size Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share Forecast Market Share Forecast
9.3.3.2.1. By Drug Type
9.3.3.2.2. By Therapy
9.3.3.2.3. By Drug Therapy
9.3.3.2.4. By Route of Administration
9.3.3.2.5. By Gender
9.3.3.2.6. By Cancer Type
12
  • Table of Contents

S. No. Contents Contents Contents Contents Contents Page No.
10. South America Oncology Drugs Market Outlook South America Oncology Drugs Market Outlook South America Oncology Drugs Market Outlook South America Oncology Drugs Market Outlook South America Oncology Drugs Market Outlook
10.1. Market Size Forecast Market Size Forecast
10.1.1. By Value By Value By Value
10.2. Market Share Forecast Market Share Forecast
10.2.1. By Drug Type By Drug Type By Drug Type
10.2.2. By Therapy By Therapy By Therapy
10.2.3. By Drug Therapy By Drug Therapy By Drug Therapy
10.2.4. By Route of Administration By Route of Administration By Route of Administration
10.2.5. By Gender By Gender By Gender
10.2.6. By Cancer Type By Cancer Type By Cancer Type
10.2.7. By Country (Brazil, Argentina, Colombia) By Country (Brazil, Argentina, Colombia) By Country (Brazil, Argentina, Colombia)
10.3. South America Country Analysis South America Country Analysis South America Country Analysis South America Country Analysis
10.3.1. Brazil Oncology Drugs Market Outlook Brazil Oncology Drugs Market Outlook Brazil Oncology Drugs Market Outlook
10.3.1.1. Market Size Forecast Market Size Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share Forecast Market Share Forecast
10.3.1.2.1. By Drug Type
10.3.1.2.2. By Therapy
10.3.1.2.3. By Drug Therapy
10.3.1.2.4. By Route of Administration
13
  • Table of Contents

S. No. Contents Contents Contents Contents Contents Page No.
10.3.1.2.5. By Gender
10.3.1.2.6. By Cancer Type
10.3.2. Argentina Oncology Drugs Market Outlook Argentina Oncology Drugs Market Outlook Argentina Oncology Drugs Market Outlook
10.3.2.1. Market Size Forecast Market Size Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share Forecast Market Share Forecast
10.3.2.2.1. By Drug Type
10.3.2.2.2. By Therapy
10.3.2.2.3. By Drug Therapy
10.3.2.2.4 By Route of Administration
10.3.2.2.5. By Gender
10.3.2.2.6. By Cancer Type
10.3.3. Colombia Oncology Drugs Market Outlook Colombia Oncology Drugs Market Outlook Colombia Oncology Drugs Market Outlook
10.3.3.1. Market Size Forecast Market Size Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share Forecast Market Share Forecast
10.3.3.2.1. By Drug Type
10.3.3.2.2. By Therapy
10.3.3.2.3. By Drug Therapy
10.3.3.2.4. By Route of Administration
10.3.3.2.5. By Gender
10.3.3.2.6. By Cancer Type
14
  • Table of Contents

S. No. Contents Contents Contents Contents Contents Page No.
11. Middle East and Africa Oncology Drugs Market Outlook Middle East and Africa Oncology Drugs Market Outlook Middle East and Africa Oncology Drugs Market Outlook Middle East and Africa Oncology Drugs Market Outlook Middle East and Africa Oncology Drugs Market Outlook
11.1. Market Size Forecast Market Size Forecast
11.1.1. By Value By Value By Value
11.2. Market Share Forecast Market Share Forecast
11.2.1. By Drug Type By Drug Type By Drug Type
11.2.2. By Therapy By Therapy By Therapy
11.2.3. By Drug Therapy By Drug Therapy By Drug Therapy
11.2.4. By Route of Administration By Route of Administration By Route of Administration
11.2.5. By Gender By Gender By Gender
11.2.6. By Cancer Type By Cancer Type By Cancer Type
11.2.7. By Country (South Africa, Saudi Arabia, UAE, Kuwait) By Country (South Africa, Saudi Arabia, UAE, Kuwait) By Country (South Africa, Saudi Arabia, UAE, Kuwait)
11.3. Middle East and Africa Country Analysis Middle East and Africa Country Analysis Middle East and Africa Country Analysis Middle East and Africa Country Analysis
11.3.1. South Africa Oncology Drugs Market Outlook South Africa Oncology Drugs Market Outlook South Africa Oncology Drugs Market Outlook
11.3.1.1. Market Size Forecast Market Size Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share Forecast Market Share Forecast
11.3.1.2.1. By Drug Type
11.3.1.2.2. By Therapy
11.3.1.2.3. By Drug Therapy
11.3.1.2.4. By Route of Administration
15
  • Table of Contents

S. No. Contents Contents Contents Contents Contents Page No.
11.3.1.2.5. By Gender
11.3.1.2.6. By Cancer Type
11.3.2. Saudi Arabia Oncology Drugs Market Outlook Saudi Arabia Oncology Drugs Market Outlook Saudi Arabia Oncology Drugs Market Outlook
11.3.2.1. Market Size Forecast Market Size Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share Forecast Market Share Forecast
11.3.2.2.1. By Drug Type
11.3.2.2.2. By Therapy
11.3.2.2.3. By Drug Therapy
11.3.2.2.4 By Route of Administration
11.3.2.2.5. By Gender
11.3.2.2.6. By Cancer Type
11.3.3. UAE Oncology Drugs Market Outlook UAE Oncology Drugs Market Outlook UAE Oncology Drugs Market Outlook
11.3.3.1. Market Size Forecast Market Size Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share Forecast Market Share Forecast
11.3.3.2.1. By Drug Type
11.3.3.2.2. By Therapy
11.3.3.2.3. By Drug Therapy
11.3.3.2.4. By Route of Administration
11.3.3.2.5. By Gender
11.3.3.2.6. By Cancer Type
16
  • Table of Contents

S. No. Contents Contents Contents Contents Contents Page No.
11.3.4. Kuwait Oncology Drugs Market Outlook Kuwait Oncology Drugs Market Outlook Kuwait Oncology Drugs Market Outlook
11.3.4.1. Market Size Forecast Market Size Forecast
11.3.4.1.1. By Value
11.3.4.2. Market Share Forecast Market Share Forecast
11.3.4.2.1. By Drug Type
11.3.4.2.2. By Therapy
11.3.4.2.3. By Drug Therapy
11.3.4.2.4. By Route of Administration
11.3.4.2.5. By Gender
11.3.4.2.6. By Cancer Type
12. Market Dynamics Market Dynamics
12.1. Drivers Drivers Drivers Drivers
12.2. Challenges Challenges Challenges Challenges
13. Market Trends Developments Market Trends Developments Market Trends Developments Market Trends Developments Market Trends Developments
14. Competitive Landscape Competitive Landscape Competitive Landscape Competitive Landscape Competitive Landscape
15. Strategic Recommendations Strategic Recommendations Strategic Recommendations Strategic Recommendations Strategic Recommendations Strategic Recommendations
16. About Us Disclaimer About Us Disclaimer About Us Disclaimer About Us Disclaimer About Us Disclaimer About Us Disclaimer
17
RESEARCH METHODOLOGY
18
  • Research Methodology

Market Profiling
Data Analysis
Data Collection
Data Validation
Developing List of Respondents
Formulating Questionnaire
In-depth secondary research was conducted to
determine top players in the global oncology
drugs market, overall market size and segmental
market size.
The data was scrutinized using MS-Excel,
statistical tools and internal proprietary
database to obtain qualitative and quantitative
insights about the global oncology drugs market.
Data obtained as a result of primary and
secondary research was validated through rigorous
triangulation.
TechSci conducted interviews with industry
experts and industry players for data collection
and verification.
In order to conduct industry experts interviews,
TechSci formulated a detailed discussion guide.
List of industry players and industry specialists
was developed.
Primary Research
Desk Research
Company Analysis
  • Recent Developments
  • Market Changing Aspects/Dynamics
  • Government Policies
  • Conclusion
  • Market Participants
  • Key Strengths
  • Identifying Key Opinion Leaders
  • Questionnaire Design
  • In-depth Interviews

19
  • Research Methodology
  • Baseline Methodology
  • Our dedicated team of industry experts has
    monitored and analyzed various aspects of the
    global oncology drugs market. The team has
    analyzed the outlook of various segments of this
    market, while considering the major influencing
    factors such as growing RD activities for the
    development of new cancer drugs. The study
    includes market forecasting, which would enable
    our clients to take better decisions while
    planning their strategy to achieve sustainability
    in the global oncology drugs market.
  • Methodology Followed for Calculation of Market
    Size
  • Market Size by Value Market size, in terms of
    value, for the year 2019 was calculated based on
    information collected through exhaustive
    secondary research and primary surveys, with
    various key opinion leaders/stakeholders, such as
    oncology drugs companies, channel partners,
    market influencers end-users, industry experts,
    and other industry participants.
  • The team interviewed more than 15 20 oncology
    drugs companies, 100 120 end-users, and 15 20
    industry experts and other value chain
    stakeholders in the global oncology drugs market
    to obtain the overall market size from 2015 to
    2019, which was validated by the Delphi
    technique. Taking standard deviation into
    consideration, the market size was averaged out,
    to arrive at the market size data during
    2015-2019.

20
  • Research Methodology
  • Respondents were asked about the current and
    future market growth rates, market shares by drug
    type, by therapy, by drug therapy, by route of
    administration, by gender, by cancer type, by
    distribution channel, by company and by region.
    Removing the outlier responses, the geometric
    mean of growth estimates and provider wise
    revenue shares generated across various segments
    were considered, to arrive at the final revenue
    shares. Revenue shares generated across various
    segments were further triangulated from other
    stakeholders.
  • Methodology Followed for Calculation of Market
    Shares
  • Market share by drug type, by therapy, by drug
    therapy, by route of administration, by gender,
    by cancer type, by distribution channel, by
    company and by region were calculated based on
    the responses received through primary surveys
    with industry experts, in which the respondents
    were asked about the market shares or revenue
    generated from various segments of oncology drugs
    markets. The final shares were calculated by
    taking the geometric mean of the responses
    gathered from key opinion leaders after
    eliminating the outliers.
  • Methodology Followed for Forecasting
  • TechSci Research performed periodical checks on
    data collected through the surveys with logic
    checks and analyzed the survey results in
    SPSS/Tableau Software.
  • Data triangulation techniques were applied to
    fill the gaps and to present a more meaningful
    picture of the market. To forecast global
    oncology drugs market, TechSci Research used
    various forecast techniques such as
  • Moving Average
  • Time Series Analysis
  • Regression Analysis
  • Econometric and Judgmental Analysis

21
  • Research Methodology

TechSci Research used its own forecast tool,
which is based on the growth of various allied
industries in respective regions. TechSci
Research also used the impact analysis during
short, medium and long term period to estimate
the demand and to reach accurate market numbers.
It should be noted that the figures compiled are
only for the organized market including market
share data. The currency used in the report is
the United States Dollar (USD), with the market
size indicated in USD million.
Partial List of Companies Interviewed Key Secondary Sources
Abbott Laboratories AbbVie Inc Roche Holding AG Novartis International AG Johnson Johnson Bristol-Myers Squibb Company Celgene Corporation Merck Co., Inc Pfizer Inc. Eli Lilly AstraZeneca PLC Takeda Pharmaceutical Amgen Astellas Pharma Sanofi SA Eisai Thermo Fisher Scientific Astex Pharmaceutical Daiichi Sankyo Teva Pharmaceutica World Bank TechSci Research Proprietary Database Knowledge Repository Company Annual Reports Industry Magazines Industry Reports News Dailies Credible Paid Databases
22
  • INDUSTRY BRIEF

According to TechSci Research report, Global
Oncology Drugs Market By Drug Type, By Therapy,
By Drug Therapy, By Route of Administration, By
Gender, By Cancer Type, By Distribution Channel,
By Region, Competition, Forecast Opportunities,
2025, the global oncology drug market is
anticipated to continue following its growth
trajectory through 2025 due to rising prevalence
of cancer worldwide, increasing geriatric
population and growing healthcare expenditure.
Other key drivers behind the growth of this
market are increasing number drug approvals,
emergence of biosimilar products for cancer
treatment, growing research development
activities for developing new cancer drugs and
increasing governments' expenditure on healthcare
infrastructure. The fatal nature of cancer and
low rate of success for treatments, has compelled
medical practitioners to conduct new research
methodologies for better and advanced treatments.
Population in various developed countries like
the US are projected to become increasingly aged
and show rising obesity incidence, which will
drive both cancer prevalence and consequently
revenue growth for its treatments in the coming
years. But apart from the factors leading to
growth of oncology drugs market, there are some
restrains as well. The side effects and long-term
sequelae of anti-cancer chemotherapy tend to
impede the market growth. Also, adverse effects
of oncology drugs and expensive treatments pose
hindrance to the growth of the market, globally.
The global oncology drugs market is segmented
based on drug type, therapy, drug therapy, route
of administration, gender, cancer type,
distribution channel and region. Based on drug
type, the market is segmented into cytotoxic
drugs, targeted drugs and hormonal drugs. The
targeted therapy and chemotherapy segments
cumulatively hold majority share in the global
oncology drugs market. The targeted therapy kills
only malignant cells and has good survival rates.
However, the immunotherapy segment is expected to
register the highest growth rate during the
forecast period owing to higher rates of survival
and remission related to their use. Based on
cancer type, the market is segmented into lung
cancer, stomach cancer, colorectal cancer, breast
cancer, prostate cancer, liver cancer, esophagus
cancer, cervical cancer, kidney cancer, bladder
cancer and others. The lung cancer segment holds
the largest share in the global oncology drugs
market due to high prevalence of the disease,
globally. AbbVie Inc, Roche Holding AG, Novartis
International AG, Johnson Johnson,
Bristol-Myers Squibb Company, Celgene
Corporation, Merck Co., Inc, Pfizer Inc., Eli
Lilly, AstraZeneca PLC, Takeda Pharmaceutical,
Amgen, Astellas Pharma, Sanofi SA , Eisai Inc.,
Abbott Laboratories, Thermo Fisher Scientific,
Astex Pharmaceutical, Daiichi Sankyo and Teva
Pharmaceutical are some of the leading players
operating in global oncology drugs market. Key
manufacturers are trying to focus on introducing
more personalized medicines to target cancer
treatment and thereby enhance their market share.
They are also focusing on strategies such as
mergers with research institutes and acquisition
of small market players in order to grab higher
market share. North American players hold a
strong dominance in the global oncology drugs
market as they have better medical treatment
options available and companies out there have a
significantly higher focus on RD activities. US
and Canada register highest survival rate during
the course of cancer treatment. Increasing
product approvals by regulatory bodies for the
treatment of various cancers is also positively
impacting the market. Altogether, the future of
global oncology drugs market is bright with
development of pipeline oncology products and
expiry of key patents providing opportunities for
drug manufacturers., said Mr. Karan Chechi,
Research Director with TechSci Research, a
research based global management consulting firm.
23
  • SAMPLE DATA - SNAPSHOT

Global Oncology Drugs Market Size, By Value (USD
Million), 2015-2025F
CAGR By Value
CAGR By Value
YY
XX
North America Oncology Drugs Market Share, By
Drug Type, By Value, 20152025F
United States Oncology Drugs Market Share, By
Route of Administration, By Value, 20152025F
24
  • REPORT ORDERING

Report Name GLOBAL ONCOLOGY DRUGS
MARKET FORECAST OPPORTUNITIES 2015 2025
Report Price
License Type Price
Electronic Access - Single User License 4450
Electronic Access - Multi-User License 5450
Custom Research License 9450
To View Sample OR Purchase Report
25
About Us Disclaimer
TechSci Research is a global market research and
consulting company with offices in the US, UK and
India. TechSci Research provides market research
reports in number of areas to organizations. The
company uses innovative business Modes that focus
on improving productivity, while ensuring
creation of high-quality reports. The proprietary
forecasting Modes use various analyses of both
industry-specific and macroeconomic variables on
a state-by-state basis to produce a unique
bottom-up Mode of a country, regional and
global industry prospects. Combined with the
detailed analysis of company activity and
industry trends, the result is a uniquely rich
evaluation of the opportunities available in the
market.
Related Reports
  • Global Clinical Diagnostics Market By Virus Type
    of Test (Lipid Panel, Metabolic Panel, Infectious
    Disease Testing, Others), By Virus Type
    (Instruments, Reagents, Assays and Kits,
    Software), By Genetic Information (Infectious
    Disease (COVID-19, Sepsis, HIV , Others),
    Cardiology, Cancer), By Region, Competition,
    Forecast Opportunities, 2025
  • Global Electronic Skin Patches Market By Genetic
    Information (Cardiovascular Monitoring, Wireless
    Inpatient Monitoring, Diabetes Management,
    Iontophoresis Skin patches, Sweat Sensing), By
    Material (Silicon Based, Polymer Based and
    Others), By Test Type (Disposable and Reusable),
    By End User (Hospitals, Ambulatory Surgical
    Centers and Others), By Region, Forecast
    Opportunities, 2025

TechSci Research North America 708 Third
Avenue, Manhattan, New York, United States Tel
1- 646- 360- 1656 Email sales_at_techsciresearch.co
m www.techsciresearch.com
TechSci Research Europe 54, Old brook,
Bretton, Peterborough, United Kingdom Email
sales_at_techsciresearch.com www.techsciresearch.com
TechSci Research Asia-Pacific B 44, Sector
57, Noida, National Capital Region, U.P. -
India Tel 91-120-4523900 Email
sales_at_techsciresearch.com www.techsciresearch.com
Disclaimer
The contents of this report are based on
information generally available to the public
from sources believed to be reliable. No
representation is made that it is timely,
accurate or complete. TechSci Research has taken
due care and caution in compilation of data as
this has been obtained from various sources
including which it considers reliable and
firsthand. However, TechSci Research does not
guarantee the accuracy, adequacy or completeness
of any information and it is not responsible for
any errors or omissions or for the results
obtained from the use of such information and
especially states that it has no financial
liability whatsoever to the subscribers / users
of this report. The information herein, together
with all estimates and forecasts, can change
without notice. All the figures provided in this
document are indicative of relative market size
and are strictly for clients internal
consumption. Usage of the same for purpose other
than internal will require prior approval of
TechSci Research.
Write a Comment
User Comments (0)